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Pain is associated with most bony pathologies. Clinical and experimental observations
suggest that bone pain can be derived from noxious stimulation of the periosteum or
bone marrow. Sensory neurons are known to innervate the periosteum and marrow
cavity, and most of these have a morphology and molecular phenotype consistent with
a role in nociception. However, little is known about the physiology of these neurons,
and therefore information about mechanisms that generate and maintain bone pain is
lacking. The periosteum has received greater attention relative to the bone marrow,
reflecting the easier access of the periosteum for experimental assessment. With the
electrophysiological preparations used, investigators have been able to record from
single periosteal units in isolation, and there is a lot of information available about how they
respond to different stimuli, including those that are noxious. In contrast, preparations
used to study sensory neurons that innervate the bone marrow have been limited to
recording multi-unit activity in whole nerves, and whilst they clearly report responses to
noxious stimulation, it is not possible to define responses for single sensory neurons
that innervate the bone marrow. There is only limited evidence that peripheral sensory
neurons that innervate bone can be sensitized or that they can be activated by multiple
stimulus types, and at present this only exists in part for periosteal units. In the central
nervous system, it is clear that spinal dorsal horn neurons can be activated by noxious
stimuli applied to bone. Some can be sensitized under pathological conditions and may
contribute in part to secondary or referred pain associated with bony pathology. Activity
related to stimulation of sensory nerves that innervate bone has also been reported
in neurons of the spinoparabrachial pathway and the somatosensory cortices, both
known for roles in coding information about pain. Whilst these provide some clues as
to the way information about bone pain is centrally coded, they need to be expanded to
further our understanding of other central territories involved. There is a lot more to learn
about the physiology of peripheral sensory neurons that innervate bone and their central
projections.
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INTRODUCTION
This review aims to summarize and critically evaluate our current understanding of the
physiological properties of peripheral sensory neurons that innervate bone, and how information
about noxious stimulation coded by these neurons is passed through the central nervous system
to the cerebral cortex to elicit painful sensations. We begin by summarizing some key concepts
Nencini and Ivanusic Physiology of Bone Pain
regarding the quality andmanagement of bone pain, and what we
know about the morphology and molecular phenotype of bone
afferent neurons, and then we explore in detail the physiology of
bone afferent neurons and their projections through the CNS.
BONE PAIN: CLINICAL AND
EXPERIMENTAL OBSERVATIONS
Pain associated with bony pathology, including bone marrow
edema syndromes, osteomyelitis, osteoarthritis, fractures, and
bone cancer causes a major burden (both in terms of quality of
life and cost) on individuals and health care systems worldwide.
This burden is expected to increase with advances in modern
medicine that prolong life expectancy, because many of the
conditions that cause bone pain are intractable and develop
late in life. The prevalence of many of these conditions is
high, for example, osteoarthritis affects almost 10% of men
and 18% of women over 60 years of age (worldwide estimate),
and osteoporosis affects up to 30% of postmenopausal women
in northern USA (Woolf and Pfleger, 2003). Metastatic bone
pain is the most common pain syndrome reported in cancer
patients, and up to 50% of patients report the pain being
poorly managed by present treatments (Mantyh and Hunt,
2004). Management of bone pain with conventional analgesia
is based on the assumption that the mechanisms that mediate
bone pain are similar to those that mediate pain in other tissue
systems and can therefore be targeted with similar therapies.
Opioids and non-steroidal anti-inflammatory drugs (NSAIDs)
are generally used to treat mild to severe pain, but therapeutic
use for bone pain is limited by undesirable side effects including
sedation, respiratory depression, tolerance to prolonged use, risk
of addiction, gastrointestinal effects and renal toxicity. All of
these occur with prolonged use of the sort required to treat
persistent pain in intractable conditions such as osteoarthritis,
osteoporosis, and bone cancer. NSAIDs and opioid analgesia use
in the treatment of bone pain is further complicated because of
the significant undesirable effects on bone remodeling/healing
(Bove et al., 2009; Pountos et al., 2012; Chrastil et al., 2013) which
complicates the underlying pathology. Other agents that inhibit
the activity of osteoclasts (e.g., Osteoprotegerin) or that act by
reducing inflammatory processes (e.g., function blocking nerve
growth factor antibodies) produce significant analgesia in animal
models of bone cancer-induced and fracture pain (Honore et al.,
2000a; Halvorson et al., 2005; Sevcik et al., 2005; Jimenez-
Andrade et al., 2007; Koewler et al., 2007). These primarily exert
effects in the periphery and are targeted at the causes of bone
pain. However, they can have significant side effects related to
bone remodeling and/or bone destruction that have limited their
therapeutic potential (Holmes, 2012; Seidel et al., 2013). There is
a clear need to find alternative strategies to treat bone pain that
do not involve the use of NSAIDs or opioids, and are targeted
more specifically at the neural or inflammatory mechanisms that
generate and/or maintain the pain.
The origin of pain associated with bony tissues has been
a contentious issue. Early studies noted that direct, noxious
mechanical stimulation of the periosteum produced painful
percepts in human subjects (Inman and Saunders, 1944), and
indeed some more recent literature highlights the prevailing
opinion that pain from bone is generally not perceived unless the
periosteum is involved (Mach et al., 2002). Pain from periosteum
is often described as sharp and well-localized, and occurs for
example with fractures significant enough to impact on the
periosteum (Santy and Mackintosh, 2001). However, injection
of irritants into the medullary cavity is also very painful, as
is needle aspiration of bone marrow, and this pain is distinct
from that associated with disruption of the periosteum (Niv
et al., 2003). In addition, patients often perceive bone pain in
pathologies confined principally to the bonemarrow that have no
obvious periosteal involvement (e.g., intra-osseous engorgement
syndrome) (Lemperg and Arnoldi, 1978; Arnoldi, 1990). In
these cases, the pain is often described exclusively as dull and
diffuse and difficult to localize. Bone cancer-induced pain falls
within this latter category, and usually consists of background
pain that is described as constant and dull and increases in
intensity over time (Honore and Mantyh, 2000; Haegerstam,
2001). In addition, patients with bone cancer often report
another more intense pain upon movement or weight-bearing
(breakthrough pain) (Portenoy et al., 1999). Thus, it appears that
both the periosteum and the marrow cavity of bones must be
innervated by primary afferent neurons capable of transducing
and transmitting nociceptive information. These bone afferent
neurons provide the central nervous system with information
that elicits primary pain arising from bone.
Pathology in bone can also produce sensitivity to normally
innocuous stimulation (allodynia) and/or increased sensitivity
to noxious stimulation (hyperalgesia) of skin around the bone/s
involved or even of skin at distant sites. This is often described
as secondary or referred pain, and likely reflects sensitization of
cutaneous afferent neurons and/or their central projections (Ren
and Dubner, 1999a). Sensitization involves increased excitability
(reduced stimulus threshold for activation and/or an increased
frequency of action potential discharge) of peripheral and central
sensory neurons. Many experimental studies reporting pain
behavior in animal models of bony pathology use behavioral
testing platforms that assay pain, thermal or mechanical
sensitivity primarily (or exclusively) at skin around the affected
bone (Cain et al., 2001; Urch et al., 2003; Yanagisawa et al., 2010;
Uhelski et al., 2013), and so are likely to monitor mechanisms
associated with secondary or referred pain, not primary pain
associated with direct stimulation of nociceptors in bone.
MORPHOLOGY AND MOLECULAR
PHENOTYPE OF SENSORY NEURONS
THAT INNERVATE BONE
There are many studies that have reported the existence of
primary afferent neurons that innervate bone, and it has become
clear that most of these sensory neurons have a morphology
and molecular phenotype consistent with a role in nociception
(Figure 1). Here we summarize the literature that has contributed
to this understanding before discussing in detail the physiology of
sensory neurons that innervate bone. For a more detailed review
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FIGURE 1 | Morphology and molecular phenotype of sensory neurons that innervate bone. The DRG soma of primary afferent neurons that innervate the
bone marrow and periosteum are mostly small diameter myelinated and unmyelinated neurons with free fiber endings, although some larger neurons with
encapsulated endings do exist in the periosteum. They express varying combinations of markers characteristic of nociceptive neurons, including calcitonin
gene-related peptide (CGRP), substance P (SP) and the tyrosine receptor kinase A (TrkA), and/or bind isolectin B4 (IB4). IB4 binding has not been observed in
peripheral nerve terminals (represented by dotted line).
of current literature regarding the morphology and molecular
phenotype of sensory neurons that innervate bone, the reader is
referred to the following reviews: Mach et al. (2002), Jimenez-
Andrade et al. (2010), Mantyh (2014).
Most early studies of the nerve supply to bone documented
examples of dissected or silver stained nerve fibers in bone
and periosteum but paid little attention to their function (De
Castro, 1925; Hurrell, 1937; Takase andNomura, 1957;Miller and
Kasahara, 1963; Cooper et al., 1966; Sakada and Maeda, 1967a;
Calvo, 1968; Thurston, 1982). As many of these fibers were in
close apposition to blood vessels within the bone, some of the
authors suggested an association with vasculature function, but
did not comment further. This is somewhat surprising, because
damage to bone and associated tissue is clearly associated with
pain, suggesting that at least some of the reported fibers in bone
must be nociceptors. The use of immuno-histochemical markers
for various neuropeptides in more recent reports has provided
evidence that nerve fibers innervating mineralized bone, bone
marrow, and periosteum are of both sensory and autonomic
origin (Duncan and Shim, 1977; Gronblad et al., 1984; Hohmann
et al., 1986; Bjurholm et al., 1988; Hill and Elde, 1988, 1991;
Mach et al., 2002). The fibers of sensory origin were generally
described as having small diameter free fiber endings, although
some larger fibers with specialized encapsulated endings have
been reported in the mandibular periosteum of cats (Sakada
and Maeda, 1967a; Sakada and Aida, 1971b), human long bone
periosteum (Ralston et al., 1960) and Haversian canals in canine
cortical bone (Cooper et al., 1966). A newly developed technique
for selectively labeling peripheral sensory neurons could be useful
in confirming a sensory, as opposed to sympathetic origin, for
these nerve terminal endings in bone (Kyloh and Spencer, 2014;
Spencer et al., 2014).
Nociceptors are generally defined as small diameter thinly
myelinated or unmyelinated primary afferent neurons and can
be identified by the presence of specific molecular markers
expressed on their soma [in the dorsal root ganglion (DRG)]
or their peripheral nerve terminals. The DRG soma of primary
afferent neurons that innervate the medullary cavity, trabecular
bone and the periosteum are almost exclusively small diameter
myelinated and unmyelinated neurons that express varying
combinations of the markers characteristic of nociceptive
neurons, including calcitonin gene-related peptide (CGRP),
substance P (SP), and the tyrosine receptor kinase A (TrkA),
and/or bind isolectin B4 (IB4) (Gajda et al., 2004; Ivanusic, 2009;
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Aso et al., 2014). Importantly, these studies have identified sub-
populations of sensory neurons that innervate bone on the basis
of various combinations of these markers in the rat. For example
it is clear that up to half are peptidergic (CGRP+) (Ivanusic,
2009; Aso et al., 2014) and many are non-peptidergic (CGRP-
or IB4 binding) (Ivanusic, 2009; Aso et al., 2014), and that
approximately two thirds are likely to be nerve growth factor
sensitive (TrkA+) whilst others are not (TrkA-)(Aso et al., 2014).
It appears that these molecular phenotypes are maintained in
peripheral nerve terminals in bone (Mach et al., 2002; Jimenez-
Andrade et al., 2010; Castaneda-Corral et al., 2011), although
IB4 binding has not been observed at this location (at least
in mice; Mach et al., 2002). Whilst there may be some subtle
species differences, it is clear that the morphology and molecular
phenotype of sensory neurons that innervate tissues within bone
are consistent with a role in nociception, and that these features
can be used to identify multiple sub-populations of bone afferent
neurons (Figure 1). Whether, this molecular heterogeneity is
reflected in the physiology of bone afferent neurons remains to
be determined. In the rest of this review, we will explore what is
known about the physiology of bone afferent neurons.
PHYSIOLOGY OF PERIPHERAL BONE
AFFERENT NEURONS
The environment in which sensory nerve terminals exist in bone
is very different to that in other tissue types. The periosteum
lines very hard cortical bone and so sensory nerve endings
in the periosteum are easily compressed by relatively low
threshold mechanical stimuli compared to endings in more
compliant tissue such as skin. Bone marrow is surrounded by
non-compliant mineralized bone and contains large populations
of progenitor and mature inflammatory cells (and other cell
types) that together produce different stimulus conditions in the
marrow cavity compared with other tissue. Thus, it is important
to consider how primary afferent neurons in each of these
different bony compartments respond to noxious stimuli, and
how this differs from other tissue types. Here we discuss in detail
what is known of the physiology of peripherally located, primary
afferent neurons that innervate either the periosteum or the bone
marrow.
Periosteum
There is much greater attention devoted in the literature to
periosteal afferent innervation than that of the marrow cavity.
This undoubtedly reflects the easier access of the periosteum for
experimental assessment than the marrow cavity of bone.
The most detailed series of electrophysiological studies of
periosteal innervation was carried out by Sakada and colleagues
(Sakada and Maeda, 1967a,b; Sakada and Aida, 1971a,b; Sakada
and Onoe, 1971; Sakada and Taguchi, 1971; Sakada and Miyake,
1972; Sakada and Nemoto, 1972; Sakada, 1974; Sakada and
Yano, 1978). They made hundreds of recordings from small
nerves in an in vitro whole-mount preparation of the cat
mandibular periosteum describing responses to both noxious
and innocuous stimulation of their sensory nerve terminals.
Because the receptive fields of periosteal afferents in the
preparation were sufficiently discrete, the investigators were
able to activate and isolate single units with mechanical stimuli
applied at the periosteum. Histology revealed that the cat
mandibular periosteum was innervated by small diameter free
fiber endings and some larger endings encapsulated by Golgi-
Mazzoni corpuscles (Sakada andMaeda, 1967a; Sakada and Aida,
1971b). The free fiber endings were distributed across the entire
preparation, whereas the Golgi-Mazzoni corpuscles could only
be found at the midline anterior to the mental foramen. Thus,
the authors were able to preferentially activate and study free
fiber endings by applying stimuli to the periosteum posterior to
the mental foramen. They reported that most axons with free
fiber endings had small diameters, consistent with a nociceptive
function, and systematically explored the response properties of
small diameter periosteal free fiber endings in the mandibular
periosteum (see below). They also described the behavior of the
encapsulated Golgi-Mazzoni corpuscles found anterior to the
mental foramen.
Zhao and Levy described a preparation in which they
used tungsten wire electrodes to record the activity of
trigeminal ganglion neurons with receptive fields on the calvarial
periosteum of the rat (Zhao and Levy, 2014). This method allows
good isolation of single units, and all of their data are of single
unit responses to periosteal stimulation. A total of 115 single
units were reported, making it a significant sample population to
draw inferences from. They did not comment on the morphology
or size of periosteal endings, but they did carefully explore their
physiology, predominantly, but not exclusively, in the context of
roles in nociception (see below).
Mahns and colleagues used an in vivo preparation to explore
neurons that innervate the periosteum of the cat humerus
(Mahns et al., 2004, 2006). Histology revealed that the small
nerve from which recordings were made in this preparation
contained only small diameter myelinated and unmyelinated
axons (Ivanusic et al., 2006). They were able to selectively
activate individual afferent fibers that displayed circumscribed
and punctate receptive fields. However, only 15 individual fibers
were studied in terms of receptive field characteristics and/or
vibro-mechanical sensitivity and responsiveness.
Conduction Velocities
Conduction velocity is closely related to axon size and can be
used to classify primary afferent neurons into a number of
functional categories. Afferents with small diameter myelinated
(Aδ) or unmyelinated (C) axons and slow conduction velocities
are associated predominantly with a nociceptive function (Dixon,
1963; Burgess and Perl, 1973; Lawson andWaddell, 1991; Djouhri
and Lawson, 2004; Strassman et al., 2004). C fiber neurons, have
the smallest diameter axons (0.6–1.2 µm rat; 1–2 µm cat) and
the slowest conduction velocities (<2m/s rat;<10m/s cat). Their
conduction properties and responses to both heat and chemical
stimuli have led to the idea that these are important mediators
of slow, burning pain in most tissue systems. The myelinated Aδ
fiber neurons have larger sized axons (1.2–4 µm rat; 2–5 µm
cat) and faster conduction velocities (2–12m/s rat; 10–30m/s
cat). Because of their faster conduction, they are believed to be
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mediators of fast pain. Aβ neurons are also myelinated and have
the largest diameter axons (>4 µm rat; >5 µm cat) and fastest
conduction velocities (>12m/s rat; >30m/s cat). Neurons with
large diameter axons, fast conduction velocities and encapsulated
endings are typically associated with innocuous (e.g., tactile or
kinesthetic) sensibility.
Sakada and colleagues reported that the axons supplying
periosteal free fiber endings in cat mandibular periosteum
had conduction velocities in the Aδ and C fiber range (2–
18m/s) (Sakada and Maeda, 1967b; Sakada and Taguchi,
1971), suggesting a role in nociception. The axons with
encapsulated Golgi-Mazzoni endings had faster conduction
velocities (>30m/s) (Sakada andMaeda, 1967b; Sakada and Aida,
1971a), suggesting of a role predominantly in low-threshold
mechano-sensibility and not nociception. Zhao and Levy (2014)
reported similar distributions of conduction velocity across the
Aβ, Aδ, and C fiber ranges in the rat calvarial periosteum,
reinforcing the notion that periosteal afferents have roles in
both nociception and low-threshold mechano-sensibility. In
contrast, Ivanusic and colleagues reported histological findings
that the nerve to the cat humerus contained only small diameter
myelinated and unmyelinated axons (Ivanusic et al., 2006) and
conduction velocities on electrical stimulation of the periosteum
that were confined to a range consistent with Aδ and C
fiber classification (<30m/s) (Mahns et al., 2006). However,
the conduction velocity of only four periosteal afferent fibers
was presented, so their sample size is limiting. It is possible
that sampling a broader area of the periosteum of the cat
humerus may have uncovered units with faster conduction
velocities. Alternatively, it might be that units with faster
conduction velocities and larger axons are more common
in the skull (Sakada and Taguchi, 1971; Zhao and Levy,
2014) compared with the appendicular skeleton (Mahns et al.,
2006). Nonetheless, the findings from all investigators indicate
that the overwhelming majority of periosteal afferents have
conduction velocities consistent with a role in nociception,
and likely contribute to sharp, fast (Aδ) or slow burning
(C) pain. These types of pain have indeed been reported
in humans subjected to periosteal stimulation (Inman and
Saunders, 1944), and have been suggested to contribute to
pain profiles in a number of animal studies (Martin et al.,
2007).
Mechanical Response Properties
All of the above investigators have reported periosteal afferent
units to be mechanically sensitive. Sakada and colleagues
recorded many hundreds of mechanically sensitive units in their
series of papers exploring the cat mandibular periosteum but
these studies do not reveal the relative proportion of afferent
fibers that were mechanically sensitive because they studied
only those that could be identified with mechanical stimuli.
In contrast, nearly all of the units (113/115) that could be
activated by electrical stimulation of the calvarial periosteum
were mechanically sensitive (Zhao and Levy, 2014), suggesting
that the overwhelming majority of periosteal afferents are
mechanically sensitive in this preparation. Similarly, all 15 of
the sensory neurons identified with electrical stimulation of the
periosteum of the cat humerus could be activated by mechanical
stimuli (Mahns et al., 2006).
The threshold to activation is an important property of
sensory neuron physiology that informs how easily a stimulus
is transduced at the periphery. The threshold to activation for
mechanically sensitive primary afferent neurons is useful in
defining their functional classification. For example, most low-
threshold mechanically sensitive units have a role in innocuous
sensibility, whilst those with high thresholds usually have a
role in nociception. Peripheral sensory neurons can also adapt
in different ways to the application of a constant mechanical
stimulus. For rapidly adapting neurons the discharge frequency
declines very quickly and the response to themechanical stimulus
is transient such that impulses only occur at the onset or offset
of mechanical stimulation. This provides for clear temporal
localization of mechanical stimuli and is characteristic of low-
threshold mechano-sensory neurons. The Pacinian corpuscle is
an example of a rapidly adapting mechanoreceptor. For slowly
adapting neurons, the decline in discharge frequency takes much
longer, such that the neuron continues to fire for the duration of
the stimulus. The majority of nociceptors are classically defined
as having a slowly adapting response to noxious mechanical
stimulation, meaning that once activated, a nociceptor will
remain activated and provide the CNS with information about
the duration of the stimulus.
Sakada and colleagues reported that both the large,
encapsulated Golgi-Mazzoni endings, as well as the free
fiber endings posterior to the mental foramen, could be classified
according to their adaptation responses. Golgi-Mazzoni endings
were exclusively rapidly adapting, low-threshold units that
responded well to vibration, and are akin to the Pacinian
corpuscles or other afferents that mediate innocuous tactile or
kinesthetic sensibility (Sakada and Maeda, 1967b; Sakada and
Aida, 1971a). In contrast, the free fiber endings they recorded
from were either rapidly or slowly adapting, and each of these
had different response properties. The impulse patterns to
pressure stimulation of slowly adapting free fiber endings varied
greatly, however, most showed a sharp increase in activity
during the dynamic phase of the pressure stimulus, followed
by a period of sustained activity characterized by a gradual
increase in inter-spike interval as the receptor adapted to the
maintained stimulus (Sakada and Taguchi, 1971; Sakada and
Miyake, 1972). With an increase in intensity of mechanical
stimulation these slowly adapting free fiber endings displayed an
increase in frequency of discharge, at least during the dynamic
phase of their response (Sakada and Taguchi, 1971; Sakada
and Miyake, 1972). Most of these slowly adapting free fiber
endings had axons with conduction velocities in the Aδ neuron
range (2–18m/s) and had relatively high mechanical thresholds
(Sakada and Taguchi, 1971), suggesting a role in nociception.
These findings are consistent with the findings of Zhao and
Levy, who reported that 82% of the mechanosensitive afferents
in the calvarial periosteum were slowly adapting and most, but
not all had conduction velocities in the Aδ and C fiber range.
It is noteworthy that both Sakada and colleagues and Zhao
and Levy reported some slowly adapting free fiber endings
that responded to innocuous stretch of the digastric muscle
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and/or conducted in Aβ range, suggesting that some could be
innocuous mechanoreceptors rather than nociceptors, but these
were relatively few in their preparations.
In the studies of Sakada and colleagues, rapidly adapting
free fiber endings were identified by their response to vibratory
stimuli (Sakada and Onoe, 1971; Sakada and Taguchi, 1971).
Threshold to activation was measured as the minimal voltage,
applied to the solenoid of a mechanical stimulator, that was
required to elicit a 1:1 pattern of firing (one impulse per cycle
of vibration) at 10 cycles per second (Hz). Calibration to real
force was not presented so it was not possible to compare
mechanical thresholds with other studies, but they were able to
discriminate between relatively high and low threshold rapidly
adapting free fiber endings within their own studies. Rapidly
adapting free fiber endings could follow frequencies of vibration
well above 300 cycles per second (Sakada and Onoe, 1971).
Approximately half of the rapidly adapting free fiber endings in
the periosteum had low thresholds and responded to stretch of
the digastric muscle that was not considered noxious because
it did not elicit a pain reflex or a jaw opening reflex (Sakada
and Taguchi, 1971). This suggested that they were low-threshold
mechanoreceptors. The other half had relatively high thresholds
and were considered to be nociceptors (Sakada and Taguchi,
1971). All 15 mechanically sensitive fibers reported in Mahns,
Ivanusic et al. (2006) displayed rapidly adapting properties, as
step indentation of the periosteum, by means of either hand-held
probes or servo-controlled mechanical stimuli, elicited responses
only in association with the dynamic components of the stimulus.
Many of these could be activated with very low forces (as little
as 0.5mN) and conducted in the Aδ and C fiber range. They
are likely similar to the rapidly adapting free fiber endings
defined as low-threshold mechanoreceptors reported by Sakada
and colleagues.
The receptive field of a single neuron defines the area of
tissue over which an adequate stimulus can elicit activity and
therefore influences the capacity of a sensory neuron to detect
the location of a stimulus and discriminate between multiple
stimuli. Receptive fields of mechanically sensitive units can vary
in size for different types of units and in different tissue systems.
Sakada and Taguchi (1971) quantified the size of the receptive
field of 434 single units innervating the mandibular periosteum.
Most units could be activated at multiple, discrete receptive sites
over a large area of the periosteum, typically between 2 and 20
mm2. There was little difference in the receptive field size of units
that responded to stretch of the digastric muscles and those that
did not, but there may have been a very modest tendency for
slowly adapting units to have slightly larger receptive fields than
rapidly adapting units. In the case of the periosteum of the cat
humerus, each unit had a receptive field comprised of a single
locus and was usually of an approximately oval configuration
which ranged from 2 to 4 mm2 (Mahns et al., 2006). In this
latter study, individual periosteal afferent units could usually
be selectively activated with the use of fine stimulus probes,
suggesting that there is a limited overlap of the terminal receptive
fields of individual fibers in the periosteum.
Finally, it is also possible that other fibers of lesser, or no
mechanical sensitivity, innervate the periosteum, because in
regions that appeared insensitive to direct mechanical probing,
it was possible to selectively activate individual fibers by applying
focal electrical stimuli (Mahns et al., 2006). These had conduction
velocities in the C and Aδ range. They could respond to
changes in temperature or chemical stimuli instead ofmechanical
stimulation, or they could be similar to silent nociceptors
found in other tissue systems, that are typically insensitive to
mechanical stimulation under normal conditions, but become
mechanically sensitive following inflammation (Grigg et al., 1986;
Schaible and Schmidt, 1988; Schaible, 1996).
Chemical Sensitivity and Inflammatory Mediators
Chemical sensitivity and sensitization by inflammatory
mediators is typical of polymodal nociceptors, particularly
those classified as C fibers. Only a single study has tested the
chemical sensitivity of periosteal afferent neurons (Zhao and
Levy, 2014). In this study, recordings of sensory neurons that
innervate the calvarial periosteum were made before and during
application of known algesic substances, including potassium
chloride (50–500mM), capsaicin (10 µM) and protons (low
pH). Potassium chloride produced a dose dependent increase in
ongoing activity of both Aδ and C fiber periosteal afferent units,
but capsaicin and low pH rarely altered ongoing activity, and
when it did the response was of low magnitude. However, the
sensitivity of periosteal afferent units to mechanical stimuli was
clearly altered after application of inflammatory mediators. Local
applications of a mixture of histamine, serotonin, bradykinin,
and PGE2 led to increased ongoing activity in nearly one third of
mechanically sensitive Aδ units and one half of C fiber units, and
an increase in the mechanical responsiveness of nearly half of the
Aδ fiber units and all of the C fiber units tested. The mechanical
sensitization was long lasting (often more than 30 min) and was
related to peri-orbital tactile hypersensitivity, commonly linked
to primary headache attacks. Thus, sensitization of periosteal
afferent neurons can occur and likely contributes to altered
pain processing in pathology. In addition to providing evidence
that periosteal afferents can be sensitized, these findings also
highlight that some periosteal afferents can be activated by
multiple stimuli and can therefore be considered polymodal. The
idea that periosteal afferent units are polymodal was not explored
in any of the other studies of periosteal innervation described
above.
Response to Changes in Temperature
Sakada and Nemoto (1972) recorded both multi-unit and single
unit responses to dynamic changes in temperature applied to
the periosteum. This was done by recording from periosteal
nerves whilst cooling the bath solution from 32 to 27◦C and then
warming back to 31◦C. There was no spontaneous activity in the
recordings at 32◦C. The number of units active in the multi-
unit recordings increased as cooling was applied, suggesting
progressive recruitment of temperature sensitive periosteal units.
The discharge frequency of the whole nerve recordings also
increased with cooling, indicating that at least some of these
multi-units can code for the intensity or rate of change in
temperature. Interestingly, the units that responded to cold
became silent as the temperature was changed to one that is
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warming instead of cooling, suggesting they sense changes in
temperature rather than absolute temperature. This is similar
to cold receptors in the cornea (Carr et al., 2003). As the
warming continued, different units began responding to the
warming stimulus, and they too were capable of coding the
intensity or rate of change in the warming stimulus. Thus, some
periosteal afferents respond to innocuous cooling and some to
innocuous warming. Sakada andNemoto (1972) further explored
the temperature sensitivity of 93mechanically sensitive periosteal
units isolated from the whole nerve recordings by applying
temperature changes to discrete receptive points of single units
on the periosteum. Their responses to cooling were assessed
down to at least 17◦C (sometimes even down to 0◦C) and to
warming up to a maximum of 45–50◦C, ranges that include
temperatures that are considered to be noxious. 20/93 of these
did not respond to temperature changes at all, even when these
changes were extreme. 24/93 responded to cooling but not
warming, and 19/93 responded to warming but not cooling.
30/93 responded to both cooling and heating. Those in the latter
three categories were only tested to the point where threshold to
activation was reached for either cooling or heating, and so it is
not entirely clear if all of these responded into the noxious range
of temperatures, although for many the threshold to activation
itself occurred at noxious temperatures. It has to be noted,
however, that some Aδ mechanically sensitive nociceptors in the
skin have very high thresholds to heat (median threshold greater
than 53◦C) but can becomemore sensitive to thermal stimulation
following sensitization (Type I Aδ nociceptors; Treede et al.,
1995), and so the temperatures used in the study of Sakada and
Nemotomay not have been sufficient to activate some of the units
they reported to be purely mechanically sensitive.
Taken together, these findings suggest that many periosteal
free fiber endings are responsive to innocuous and noxious
thermal stimuli. However, it is unlikely that physiological changes
of temperature around bone are great enough to activate these
fibers (Sakada and Nemoto, 1972). It is also unlikely that they are
activated directly by pathological changes, because even warming
produced by inflammation in vivo (Segale, 1919) would not cause
a sufficient change in temperature to activate these receptors. It
is of course possible that whilst inflammation does not produce
changes in temperature that could activate periosteal fibers
directly, it can alter their sensitivity to thermal stimuli such that
they become more responsive to changes in temperature. Indeed
inflammation is known to increase the thermal sensitivity of
primary afferent neurons in many other tissue systems (Cervero
and Laird, 1999; Ren and Dubner, 1999b). Thus, activation of
periosteal afferents by temperature may be possible under highly
abnormal or pathological conditions.
Summary/Conclusions
Figure 2 summarizes what we know about the physiology of
sensory neurons that innervate the periosteum. The periosteum
is innervated both by large diameter, fast conducting units with
encapsulated endings that are likely to provide information about
innocuous sensibility and by small diameter, slower conducting
units with free fiber endings typical of nociceptors. Activation
of the latter is likely to generate the pain experienced during
pathology involving the periosteum. Their response properties,
including conduction velocities and responses to chemical
stimuli suggest roles in both fast, sharp bone pain, and also
slow burning bone pain. However, there is evidence that some
free fiber endings in the periosteum are activated by relatively
low thresholds. In skin, low threshold mechanical stimulation of
some small diameter, myelinated (Burgess and Perl, 1967; Burgess
et al., 1968; Koltzenburg et al., 1997) and unmyelinated (Vallbo
et al., 1993, 1999; Olausson et al., 2002) fibers produces percepts
that have been described as non-painful. Whether low threshold
free fiber endings have a role in innocuous mechanosensory
perception in bone requires further investigation (Rowe et al.,
2005), but it seems unlikely because it is difficult to conceive of
any stimulus that could be applied to bone that is not considered
painful. The alternative is that they may be easily activated by low
threshold mechanical stimulation of the periosteum because of
its tight relationship with the underlying, hard, bony surface and
could therefore contribute to periosteal pain perception. There is
also evidence that large diameter neurons in other tissue systems
can contribute to pain processing (Djouhri and Lawson, 2004).
Thus, it is possible that the reported large diameter encapsulated
endings do have some, as yet unidentified role to play in bone
pain as well.
Bone Marrow
Brjussowa and Lebedenko (1930; cited in Furusawa, 1970)
studied the reaction of dogs during the injection of physiological
saline under pressure into the bone marrow cavity. Monitoring
blood pressure and respiration, they observed that animals
experienced strong pain-like behaviors during the injection. This
suggested that there must be sensory nerves in the marrow
cavity that responded to increased pressure. Only two published
studies however, have investigated the physiology of sensory
neurons supplying the marrow cavity of bone (Furusawa, 1970;
Seike, 1976). In these studies, whole nerve recordings were made
from branches of the tibial nerve whilst mechanical, thermal or
chemical stimuli were applied to the marrow cavity. No attempt
was made to explore the activity of single units in these studies.
On the basis of histological findings, the investigators suggested
that recordings were exclusively from Aδ and C fiber units.
However, conduction velocities were not confirmed in either
study.
Mechanical Response Properties
Mechanical stimuli have been delivered to the marrow cavity by
increasing the normal intra-osseous pressure through infusion
of isotonic saline into the medullary cavity of the bone. Normal
intra-osseous pressure and the extent of the increased pressure
were monitored via a manometer attached to the system. In
the dog, the normal intra-osseous pressure of the tibial marrow
cavity was in the range of 30–50 mmHg and an ∼3–5 times
increase in intra-osseous pressure (to 100–130 mmHg) was
sufficient to mechanically activate multiple units in whole nerve
recordings (Seike, 1976). Similar activation thresholds for whole
nerve activity had previously been described by Furusawa (1970).
These are very high thresholds that are unlikely to be experienced
under normal physiological conditions. However, increases in
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FIGURE 2 | Response properties of periosteal free fiber endings. Single periosteal units respond to mechanical, chemical, and thermal stimuli. Mechanically
sensitive units can be classified according to their threshold and adaption profile. Potassium chloride activates most periosteal units dose-dependently, but capsaicin
and low pH only rarely activates them. Some periosteal units respond to cooling and heating, some to cooling but not heating, some to heating but not cooling, and
some to neither.
intra-osseous pressure (∼3–5 times that of normal intra-osseous
pressure) are experienced in pathological conditions such as
intra-osseous engorgement syndromes (Lemperg and Arnoldi,
1978; Arnoldi et al., 1980). In these cases, the increase in pressure
is associated with pain which can be relieved by fenestration,
suggesting that increased pressure in the marrow cavity produces
pain.
In the study of Seike (1976) the discharge frequency
increased immediately after the start of the pressure stimulation
suggesting a short latency response to mechanical stimuli.
The rate of discharge generally had a tendency to increase
as pressure increased, and when a stable ramp of pressure
was applied, the response gradually subsided as receptors
appeared to slowly adapt. However, it should be noted that
single units were not isolated in these studies, and so it
is not clear to what extent this adaptation profile is really
true of individual sensory neurons that innervate the marrow
cavity.
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Chemical Sensitivity
Only one study has investigated the response of sensory
receptors in bone marrow to chemical substances (Seike, 1976).
Intramedullary administration of known algesic substances
(potassium chloride, acetylcholine, histamine, serotonin, and
bradykinin) to the bone marrow cavity produced an increase in
whole nerve ongoing activity within a few minutes of injection
at concentrations comparable to those reported for activation of
muscle nociceptors (Fock and Mense, 1976). Whilst the increase
in ongoing activity and the latency of the response were reported
to be largely dependent on the concentration used for each
substance, the extent of these changes was not quantified.
Thermal Sensitivity
Seike (1976) attempted to record whole nerve activity in response
to changes in temperature within the marrow cavity following a
reduction in blood flow produced by ligature of the femoral artery
or application of vasoconstrictors. Earlier work had reported
that these manipulations produce a decrease in temperature
of the bone marrow cavity (Yamada and Yoshino, 1977). The
frequency of discharge in the whole nerve recordings increased
within 5 min of ligature and then gradually decreased back to
control levels over the next 15 min. Whilst there was a small
decrease in temperature at 5 min, the change in temperature
in the subsequent 15 min did not appear to correlate well with
frequency of discharge. Intra-osseous injection of adrenaline and
noradrenaline (vasoconstrictors) also increased the whole nerve
discharge rate. Both substances produced a more significant
fall in temperature within the marrow cavity, and a greater
change in rate of discharge of the whole nerve, than that
generated by the ligature of the femoral artery. As was the case
for ligature of the femoral artery, the relationship between the
change in temperature and discharge rate was not clear after
the initial period of activation. Although, it seems plausible
that the thermal change contributes to increased activity in the
whole nerve, hypoxia is also likely to contribute to the response.
Arterial occlusion results in severe hypoxia and an increase in
inflammatory and/or other chemical mediators (Paterson et al.,
1988). Indeed some inflammatory mediators have been shown to
change whole nerve activity when applied directly to the bone
marrow (see above). Thus, the change in temperature in this
study may not have been the stimulus that is actually driving
change in activity in the whole nerve reported by Seike (1976).
Summary/Conclusions
Figure 3 summarizes what we know about the physiology of
sensory neurons that innervate the bone marrow. In contrast
to the periosteum, there is little known about the activity of
afferent neurons in the bone marrow cavity. Whilst whole nerve
activity has been reported subsequent to mechanical, chemical,
and possibly thermal stimulation applied to the marrow cavity,
the response of single units has not been investigated. Thus, it is
not clear if and how single neurons that innervate the marrow
cavity respond to mechanical, chemical or thermal stimuli, or
if they respond to multiple stimulus types, as is the case for
polymodal nociceptors in other tissue systems. It is also unknown
if they can be sensitized by inflammatory mediators or other
chemical stimuli.
PHYSIOLOGY OF CENTRAL PATHWAYS
THAT CODE INFORMATION ABOUT BONE
PAIN
Spinal Cord
Only a few animal studies have attempted to document the
physiology of spinal neurons involved in bone nociception.
Most of these have relied on studies of activity dependent Fos
expression. Fos is a protein that is produced in the nucleus
of cells following expression of an immediate-early gene c-fos
(Coggeshall, 2005), and noxious stimuli are known to induce
c-fos expression in neurons that possess the gene. The presence
of the Fos protein, which can be labeled immunohistochemically,
can therefore be used to identify the location of neurons that have
been physiologically activated by noxious stimuli. Acute noxious
mechanical stimulation of bone, applied by bone drilling and
raising tibial intra-osseous pressure, induces an increase in Fos
expression in the ipsilateral superficial, but not deep dorsal horn
of the spinal cord (Ivanusic, 2008; Williams and Ivanusic, 2008).
This same pattern of activity has been observed in studies of
Fos expression following acute noxious stimulation of cutaneous
tissue (Dai et al., 2001; Jinks et al., 2002) and implies that
spinal mechanisms that mediate acute pain of cutaneous and
bony origin share some common features. The data implicate
the superficial dorsal horn of the spinal cord as a region of
interest in studies of acute bone pain, but it is not known if
this pattern of Fos expression is different when an inflammatory
stimulus is given. Indeed, when inflammatory agents are applied
to other tissue systems (such as skin), the pattern shifts such
that the deep dorsal horn is most active (Coggeshall, 2005). In
animal models of bone cancer-induced pain and skeletal fracture
pain, it appears there is increased Fos expression in the deep
as well as the superficial dorsal horn, and there is a significant
positive correlation between Fos expression and bone destruction
(Schwei et al., 1999; Jimenez-Andrade et al., 2007). Interestingly,
increased Fos was observed in the superficial dorsal horn in these
studies only after normally innocuous stimuli were delivered
to the femur by gentle mechanical stimulation (palpation). In
the normal animal, noxious cutaneous stimulation is required
to induce c-Fos expression in superficial dorsal neurons (Hunt
et al., 1987; Abbadie and Besson, 1993; Abbadie et al., 1994;
Honore et al., 1995; Doyle and Hunt, 1999). This suggests that
sensitization of spinal neurons is occurring in bone cancer-
induced and fracture pain.
Ascending Pathways
Williams and Ivanusic (2008) used Fos expression in
combination with retrograde tracing to identify the ascending
targets of dorsal horn neurons activated by noxious mechanical
stimulation delivered by bone drilling. They reported the
involvement of the spinoparabrachial pathway, but not the
spinothalamic tract or the post-synaptic dorsal column
in this model of acute bone nociception. This pattern of
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FIGURE 3 | Whole nerve activity subsequent to mechanical, chemical, and thermal stimulation of the bone marrow. Whole nerve activity increases in
response to mechanical stimulation delivered by increasing intra-osseous pressure. Chemical stimulation dose-dependently increases whole nerve activity.
Temperature changes produced by reductions in blood flow appear to influence whole nerve activity, but this could be due to other factors associated with interruption
of blood supply to the bone marrow (e.g., ischemia). Single units have not been tested for response to stimulation of the bone marrow.
activation is different to that observed following acute noxious
mechanical stimulation of cutaneous and visceral tissues (Palecek
et al., 2003). Spinoparabrachial projection neurons originate
predominantly from lamina I of the spinal dorsal horn and
project mostly to the contralateral lateral parabrachial nucleus
(Kitamura et al., 1993; Gauriau and Bernard, 2002; Almarestani
et al., 2007). The lateral parabrachial nucleus connects with
several areas of the brain implicated in affective-motivational
aspects of nociceptive processing and homeostatic responses
to nociceptive stimuli, including the amygdala, nucleus of the
solitary tract, ventrolateral medulla, periaqueductal gray, medial
thalamus, and hypothalamus (Bianchi et al., 1998; Almarestani
et al., 2007). This reinforces connectivity consistent with a
strong affective component to bone pain. Whilst Williams
and Ivanusic did not provide evidence of the involvement of
either the spinothalamic tract or post-synaptic dorsal column
pathways in bone nociception, they could not rule out the
possibility that these pathways may be involved in animal models
characterized by inflammatory or chronic cancer-induced pain.
As noted above, these sorts of models are characterized by
greater Fos expression in cells of the deep dorsal horn, and are
therefore more likely to project through spinothalamic tract or
post-synaptic dorsal column pathways, because the majority of
cells from these pathways originate in the deep dorsal horn of
the rat lumbar spinal cord.
Cortex
Understanding the physiology of cortical neurons activated by
noxious stimuli is important because the cortex is critical to
the perception of pain. Only a single study has shown cortical
activity related to stimulation of bone afferent neurons (Ivanusic
et al., 2009). They showed that sensory information from bone
reaches the discriminative areas of the somatosensory cortices
by electrically stimulating the nerve to the cat humerus and
recording evoked potentials on the surface of the primary
(SI) and secondary (SII) somatosensory cortex. Importantly,
the nerve to the cat humerus contains only small diameter
myelinated and unmyelinated nerve fibers, the size distribution
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(Ivanusic et al., 2006) and conduction velocities (Mahns et al.,
2006) of which are consistent with an Aδ and C fiber classification
and therefore a role in nociception. Cortical responses evoked
by Aδ stimulation in other tissue types have a relatively short
latency (within 50ms) and are thought to reflect mechanisms
associated with fast, sharp pain, whilst cortical responses evoked
by C fiber stimulation have a longer latency (50–300ms) and
are thought to reflect mechanisms associated with slow, burning
pain (Bromm and Treede, 1984; Willis, 1985). Interestingly, the
latency (6–11ms) to onset of both SI and SII cortical responses
on stimulation of the nerve to the cat humerus was consistent
with activation of Aδ fibers in the peripheral nerve, and may
reflect a mechanism for fast, sharp, and well-localized bone pain,
of the sort commonly perceived with periosteal stimulation or in
breakthrough pain associated with bone cancers. By increasing
the intensity of electrical stimulation, the authors were able to
show stronger cortical activation, implying that neurons in SI
and SII are able to code for the intensity of stimuli applied to
bone. They suggested that small stress fractures are therefore
not likely to produce significant pain because the intensity of
cortical activity may not be sufficient, whilst large breaks or
metastases are likely to produce significant pain. This mechanism
of coding for the intensity of noxious stimuli is well-documented
in animal studies of the cutaneous system (Kenshalo et al., 1988,
2000; Chudler et al., 1990), and findings of functional imaging
studies show that it is also likely to apply to humans (Porro
et al., 1998; Coghill et al., 1999). However, the investigators
failed to observe long latency cortical responses (50–300ms) that
would be consistent with C fiber activation in the nerve to the
cat humerus. Whilst they provided evidence that this may be
attributable to inhibition of cortical responsiveness following the
initial Aδ response, they could not exclude the possibility that
either C fiber projections to SI and SII are too widespread to
generate focal evoked potentials of the sort that they could record,
or that C fiber input from the nerve to the cat humerus does not
reach SI and SII at all. It is also possible that the C fiber input
instead projects to other cortical territories, such as the insula, or
subcortical areas including the amygdala, nucleus of the solitary
tract, ventrolateral medulla, periaqueductal gray, thalamus, and
hypothalamus, that have been reported to be important in the
affective, emotional aspects of pain.
PATHOPHYSIOLOGICAL CHANGES IN
ANIMAL MODELS OF BONE PAIN
A number of animal models of bony pathology have been
developed and are being used to explore pathophysiological and
neurochemical changes, in both peripheral and central neurons,
that contribute to bone pain. The most common model used
is the bone cancer-induced pain model that usually involves
inoculation of the rodent femur or tibia with tumor cells (Schwei
et al., 1999; Medhurst et al., 2002), but models of bone fracture-
induced pain are also common (Freeman et al., 2008; Minville
et al., 2008).
Several pro-inflammatory cytokines (IL-1β, TNFα, IL-6, and
TGFβ) and inflammatory mediators (CGRP) are increased in
the DRG in response to bone cancer and fracture (Kon et al.,
2001; Cho et al., 2002; Kang et al., 2005; Rundle et al., 2006;
Baamonde et al., 2007; Geis et al., 2010; Fang et al., 2015;
Hansen et al., 2016). In animals with bone cancer-induced pain
there is also increased DRG expression of several membrane
receptors/channels (TRPV1, P2X3, ASIC1a/1b, Nav 1.8, and
Nav 1.9) which are known to be involved in the transduction
of nociceptive stimuli and/or in the excitability of nociceptors
(Nagae et al., 2007; Niiyama et al., 2007; Han et al., 2012; Qiu
et al., 2012; Liu et al., 2013; Li et al., 2014). Administration of
selective antagonists or antisense oligodeoxynucleotides against
some of these channels/receptors attenuate pain-like behaviors
in animals with bone cancer pain, further reinforcing a role for
these molecules in bone pain (Ghilardi et al., 2005; Gonzalez-
Rodriguez et al., 2009; Kaan et al., 2010; Miao et al., 2010). In
other tissue systems, inflammatorymediators sensitize peripheral
nociceptors, and changes in membrane receptors/channels are
likely to be involved (Kidd and Urban, 2001). However, there is
no evidence that any of these inflammatory mediators directly
activate or sensitize bone nociceptors, or that changes in
expression of the various ion channels and receptors alter the
physiology or function of bone afferent neurons. Furthermore,
the changes observed in the DRG were not localized to sensory
neurons that innervate bone; protein expression was assayed
using Western blots of whole DRG lysates or quantified by
immunohistochemistry performedwithout retrograde labeling to
confirm that DRG neurons innervate bone. Thus, direct evidence
for a role of ion channels, receptors, and inflammatory mediators
in modulating the activity of peripheral bone afferent neurons,
and in regulating pain in bony pathology, is still lacking.
Some direct evidence of sensitization of peripheral
nociceptors in bone cancer-induced pain was provided by
Cain (Cain et al., 2001) and Uhelski (Uhelski et al., 2013). They
reported increased spontaneous activity and reduced heat (but
not mechanical) thresholds in peripherally recorded C fiber
afferents in animals that had developed behavioral sensitivity in
response to injection of tumor cells in and around the calcaneus,
but not in control animals. However, in both of these studies,
the tumor cells were not clearly confined to the bone, and the C
fibers recorded were cutaneous afferents, and so the sensitization
was not of bone afferent neurons, but rather of cutaneous
afferent neurons innervating the surrounding skin. These studies
are more relevant to an understanding of secondary or referred
pain associated with bony pathology than the pain perceived on
stimulation of the bone itself.
A number of studies have also reported changes in the
central nervous system driven by pathology in bone. Increased
expression of spinal SP, CGRP, and other inflammatorymediators
(TNF, IL-1, IL-6, CCL2, and nerve growth factor) are observed in
the spinal cord of rats with fracture-induced and bone cancer-
induced pain (Zhao et al., 2013; Shi et al., 2015). Bone cancer
induces hypertrophy of astrocytes within the spinal cord, and
elevation of the pro-hyperalgesic peptide dynorphin and c-Fos
expression in second order neurons of the deep dorsal horn
(Schwei et al., 1999; Honore et al., 2000b; Shen et al., 2014). Bone
cancer also produces alterations in the physiological response
properties of second order neurons in the spinal dorsal horn. In
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the superficial dorsal horn of animals with bone cancer, there is
enhanced spinal synaptic transmission, a higher proportion of
wide dynamic range cells, and enlarged receptive field sizes in
wide dynamic range cells (Urch et al., 2003; Donovan-Rodriguez
et al., 2004; Yanagisawa et al., 2010). Together these changes
result in a more excitable spinal cord. They are typical of central
sensitization and may underly the development of chronic bone
pain.
FINAL CONCLUSIONS
There are many studies that have reported the existence of
sensory neurons that innervate the periosteum and marrow
cavity, and it has become clear that most of these have a
morphology and molecular phenotype consistent with a role in
nociception. However, very little is known of the physiology of
these neurons. The periosteum has received greater attention
relative to the bone marrow, reflecting the easier access of the
periosteum for experimental assessment than the marrow cavity
of bone. Electrophysiological recordings of sensory neurons in
both the periosteum and the bone marrow have confirmed that
they both contain nociceptors likely to provide the CNS with
information about bone pain. The periosteum (but not the bone
marrow) is also innervated by neurons that have properties
suggesting they may be stretch receptors or impart innocuous
sensibility, although it is not clear if the latter is relevant to
stimuli applied to bone. There is only limited evidence that
peripheral bone afferent neurons can be sensitized or that they
can be activated by multiple stimulus types, and at present this
only exists in part for periosteal units. In the central nervous
system, it is clear that spinal dorsal horn neurons can be activated
by noxious stimuli applied to bone. Some can be sensitized
under pathological conditions and may contribute to secondary
hyperalgesia or referred pain associated with bony pathology.
There are only a few studies of ascending pathways and cortical
territories involved.Whilst these provide some clues as to the way
information about bone pain is centrally coded, they need to be
expanded to further our understanding of other central territories
involved. There is a lot more to learn about the physiology of
bone afferent neurons, and their central projections, before we
approach an understanding that could inform the way we think
about and manage bone pain.
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